Dolby Laboratories Reports Third Quarter Fiscal 2013 Financial Results

Updated

Dolby Laboratories Reports Third Quarter Fiscal 2013 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)-- Dolby Laboratories, Inc. (NYS: DLB) today announced the Company's financial results for the third quarter of fiscal year 2013. For the third quarter, Dolby reported total revenue of $207.1 million, compared to $210.3 million for the third quarter of fiscal year 2012.

Third quarter GAAP net income was $30.2 million, or $0.29 per diluted share, compared to $51.5 million, or $0.48 per diluted share, for the third quarter of fiscal 2012. On a non-GAAP basis, third quarter net income was $48.5 million, or $0.47 per diluted share, compared to $60.8 million, or $0.57 per diluted share, for the third quarter of fiscal 2012. Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.


"Licensing revenue increased year over year, with growth in our mobile and broadcast businesses offsetting weaker demand for PCs and consumer electronics this quarter," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While the current consumer-spending environment is weak, we continue to make solid progress on our long-term growth initiatives."

Financial Outlook

Q4 2013

Dolby anticipates total revenue for the fourth quarter (Q4) of fiscal year 2013 to range from $205 million to $215 million. Gross margin percentages are projected to be approximately 90% on a GAAP basis and 91% on a non-GAAP basis.

Dolby anticipates that operating expenses will be approximately $142 million on a GAAP basis and $124 million on a non-GAAP basis.

Dolby expects diluted earnings per share to be between $0.30 and $0.36 on a GAAP basis and between $0.45 and $0.51 on a non-GAAP basis.

The Company estimates that its fiscal Q4 2013 effective tax rate will range from 27% to 28% on both a GAAP and non-GAAP basis.

FISCAL YEAR 2013

Dolby now anticipates that total revenue for fiscal year 2013 will range from $900 million to $910 million.

Dolby now anticipates that operating expenses will be approximately $574 million on a GAAP basis and $496 million on a non-GAAP basis.

The Company's Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby Laboratories' third quarter fiscal 2013 financial results at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, July 25, 2013. Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 1-888-329-8903. International callers can access the conference call at 1-719-457-2601.

A replay of the call will be available from 5:00 p.m. PT on Thursday, July 25, 2013, until 9:00 p.m. PT on Thursday, August 1, 2013, by dialing 1-877-870-5176 (international callers can access the replay by dialing 1-858-384-5517) and entering the confirmation code 3172721. An archived version of the teleconference will also be available on the Dolby Laboratories website, www.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides non-GAAP financial measures of gross margin, operating expense, net income, and diluted earnings per share. These measures are adjusted to exclude amounts related to stock-based compensation, expense associated with dividend equivalents paid on restricted stock units, the amortization of intangibles from business combinations, restructuring charges, and the related tax impact of these items. Dolby presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures in order to assess the performance of Dolby's business for planning and forecasting in subsequent periods. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its SEC filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on Dolby's investor relations website at http://investor.dolby.com/medialist.cfm.

Forward-Looking Statements

Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial results for Q4 2013 and fiscal 2013 and Dolby's long-term growth initiatives are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates, including the personal computer, DVD, and Blu-ray Disc™, broadcast, consumer electronics, gaming, mobile, and automobile markets; pricing pressures; risks associated with the rate at which original equipment manufacturers (OEMs) include optical disc playback in Windows® 8 devices and the rate of consumer adoption of Windows operating systems; risks that a shift from disc-based media to online media content could result in fewer devices with Dolby® technologies; risks associated with the effects of macroeconomic conditions, including trends in consumer spending; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees; Dolby's accuracy of calculation of royalties due to its licensors; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; the development and growth of the market for digital cinema and digital 3D and Dolby's ability to successfully penetrate this market; Dolby's ability to expand its business generally, and to expand its business beyond sound technologies to other technologies related to digital entertainment delivery, by acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's Securities and Exchange Commission filings and reports, including the risks identified under the section captioned "Risk Factors" in its most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYS: DLB) is the global leader in technologies that are essential elements in the best entertainment experiences. Founded in 1965 and best known for high-quality audio and surround sound in environments from the cinema to the living room to mobile devices, Dolby creates innovations that enrich entertainment at the movies, at home, or on the go. For more information about Dolby Laboratories or Dolby technologies, please visit www.dolby.com.

Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. Blu-ray Disc is a trademark of the Blu-ray Disc Association. Windows is a registered trademark of Microsoft Corporation. S13 /27158DLB-F

DOLBY LABORATORIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

Fiscal Quarter Ended

Fiscal Year-to-Date Ended

June 28,
2013

June 29,
2012

June 28,
2013

June 29,
2012

Revenue:

Licensing

$

184,707

$

180,886

$

616,038

$

609,159

Products

17,381

22,132

60,605

75,760

Services

4,986

7,304

16,379

22,340

Total revenue

207,074

210,322

693,022

707,259

Cost of revenue:

Cost of licensing

4,053

2,892

13,542

9,523

Cost of products

16,269

14,529

47,964

46,052

Cost of services

4,018

3,610

11,722

9,458

Total cost of revenue

24,340

21,031

73,228

65,033

Gross margin

182,734

189,291

619,794

642,226

Operating expenses:

Research and development

42,915

35,123

127,299

102,185

Sales and marketing

58,528

49,269

175,079

138,779

General and administrative

38,413

36,859

123,324

109,605

Restructuring charges / (credits)

5,930

(85

)

5,930

1,193

Total operating expenses

145,786

121,166

431,632

351,762

Operating income

36,948

68,125

188,162

290,464

Interest income

820

1,513

3,063

4,664

Interest expense

(77

)

(26

)

(504

)

(57

)

Other income, net

156

709

1,057

969

Income before income taxes

37,847

70,321

191,778

296,040

Provision for income taxes

(7,345

)

(18,915

)

(47,560

)

(82,951

)

Net income including controlling interest

30,502

51,406

144,218

213,089

Less: net (income) / loss attributable to controlling interest

(286

)

123

(742

)

(281

)

Net income attributable to Dolby Laboratories, Inc.

$

30,216

$

51,529

$

143,476

$

212,808

Net income per share:

Basic

$

0.30

$

0.48

$

1.41

$

1.97

Diluted

$

0.29

$

0.48

$

1.39

$

1.96

Weighted-average shares outstanding:

Basic

101,751

106,328

101,917

107,876

Diluted

103,031

107,202

102,999

108,493

DOLBY LABORATORIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

June 28,
2013

September 28,
2012

ASSETS

Current assets:

Cash and cash equivalents

$

408,561

$

492,600

Short-term investments

109,342

302,693

Accounts receivable, net

74,528

43,495

Inventories

12,795

16,700

Deferred taxes

79,114

80,966

Prepaid expenses and other current assets

30,200

33,832

Total current assets

714,540

970,286

Long-term investments

335,371

361,614

Property, plant and equipment, net

245,667

254,676

Intangible assets, net

44,736

56,526

Goodwill

278,718

281,375

Deferred taxes

36,591

22,634

Other non-current assets

11,827

13,687

Total assets

$

1,667,450

$

1,960,798

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

8,845

$

14,831

Accrued liabilities

119,154

116,092

Income taxes payable

1,012

2,424

Deferred revenue

23,233

23,493

Total current liabilities

152,244

156,840

Long-term deferred revenue

19,073

18,192

Deferred taxes

2,696

Other non-current liabilities

46,271

39,837

Total liabilities

217,588

217,565

Stockholders' equity:

Class A common stock

47

46

Class B common stock

55

57

Additional paid-in capital

17,111

Retained earnings

1,408,587

1,709,479

Accumulated other comprehensive income

5,812

10,687

Total stockholders' equity - Dolby Laboratories, Inc.

1,431,612

1,720,269

Controlling interest

18,250

22,964

Total stockholders' equity

1,449,862

1,743,233

Total liabilities and stockholders' equity

$

1,667,450

$

1,960,798

DOLBY LABORATORIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Fiscal Quarter Ended

Fiscal Year-to-Date Ended

June 28,
2013

June 29,
2012

June 28,
2013

June 29,
2012

Operating activities:

Net income including controlling interest

$

30,502

$

51,406

$

144,218

$

213,089

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

13,195

11,086

39,615

31,189

Stock-based compensation

17,283

10,741

49,932

34,243

Amortization of premium on investments

2,148

3,974

8,101

13,280

Excess tax benefit from exercise of stock options

(17

)

(516

)

(621

)

(941

)

Provision for doubtful accounts

(359

)

317

(89

)

449

Deferred income taxes

(2,396

)

2,955

(12,973

)

(7,075

)

Other non-cash items affecting net income

72

(2,199

)

(800

)

38

Changes in operating assets and liabilities:

Accounts receivable

17,119

11,256

(30,829

)

15,359

Inventories

6,390

4,399

5,636

5,275

Prepaid expenses and other assets

4,023

1,710

6,924

582

Accounts payable and other liabilities

1,302

Advertisement